Stable expression of temperature-sensitive p53: A suitable model to study wild-type p53 function in pancreatic carcinoma cells

被引:9
作者
Nuevemann, Dieter [1 ]
Christgen, Matthias [1 ]
Ungefroren, Hendrik [1 ]
Kalthoff, Holger [1 ]
机构
[1] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Res Unit Mol Oncol, D-24105 Kiel, Germany
关键词
AsPC-1; tsp53; p21waf1; bax; cell cycle;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Pancreatic adenocarcinoma is an extremely aggressive malignancy with a dismal prognosis. Inactivation of the p53 tumor-suppressor gene occurs in approximately 50% of primary tumors and is thought to account for a failure of the tumor cells to undergo growth arrest and apoptosis in response to chemotherapy. Hence, it is of interest to study the consequences of the restoration of wild-type (wt) p53 function in pancreatic carcinoma cells. Therefore, we retrovirally transduced temperature-sensitive (ts) human p53 into the p53-null pancreatic carcinoma cell line AsPC-1. ts p53 has a mutant phenotype at 37.5 degrees C, and a wt conformation at 32.5 degrees C. Stable expression of p53 in wt conformation caused upregulation of the p53 responsive gene p21(Waf1/Cip1), and G, growth arrest, but failed to induce Bax expression or apoptosis. In addition, we examined the effect of wt p53 expression on DNA damaging treatment. Interestingly, the doxorubicin- and radiation-induced S-/G(2)-phase arrests were suppressed by p53 in wt conformation. These results demonstrate that the ts p53/AsPC-1 model is suitable to investigate the effect of wt p53 restoration in pancreatic carcinoma cells.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 19 条
[1]
COMPARATIVE-ANALYSIS OF MUTATIONS IN THE P53 AND K-RAS GENES IN PANCREATIC-CANCER [J].
BERROZPE, G ;
SCHAEFFER, J ;
PEINADO, MA ;
REAL, FX ;
PERUCHO, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) :185-191
[2]
Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-β in pancreatic tumor cells [J].
Chen, WB ;
Lenschow, W ;
Tiede, K ;
Fischer, JW ;
Kalthoff, H ;
Ungefroren, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :36118-36128
[3]
CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24
[4]
Amplification of AKT2 in human pancreatic cancer cells and inhibition of ATK2 expression and tumorigenicity by antisense RNA [J].
Cheng, JQ ;
Ruggeri, B ;
Klein, WM ;
Sonoda, G ;
Altomare, DA ;
Watson, DK ;
Testa, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3636-3641
[5]
WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[6]
Control of apoptosis by p53 [J].
Fridman, JS ;
Lowe, SW .
ONCOGENE, 2003, 22 (56) :9030-9040
[7]
HAHN SA, 1995, CANCER RES, V55, P4670
[8]
Cancer statistics, 2002 [J].
Jemal, A ;
Thomas, A ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (01) :23-47
[9]
Kimura M, 1997, ANTICANCER RES, V17, P879
[10]
Stable reintroduction of wild-type p53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells [J].
Lang, D ;
Miknyoczki, SJ ;
Huang, LY ;
Ruggeri, BA .
ONCOGENE, 1998, 16 (12) :1593-1602